Prognostic value of programmed cell death ligand 1 (PD-L1) expression in patients with stage III non-small cell lung cancer under different treatment types: a retrospective study.
Nicoly Marques de CastroFernando MouraAline Lury HadaDiogo GarciaElivane da Silva VictorGustavo SchvartsmanLeonardo CarvalhoMilena Lourenço Coleta FernandesRodrigo de Souza MartinsElaine Ferreira da SilvaSarah Silva Mello Batista Dos SantosLetícia TaniwakiPatrícia TarantoJanaina PontesJuliana Rodrigues BealAna Carolina Pereira DutraJoão Bosco de Oliveira FilhoSérgio Eduardo Alonso AraujoPedro Luiz Serrano UsÓn JuniorPublished in: Einstein (Sao Paulo, Brazil) (2024)
PD-L1 expression was not correlated with EC III non-small cell lung cancer outcomes. Whether these findings differ from the association with immune checkpoint inhibitors remains to be addressed in future studies.